You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ssri

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in Hangzhou (SSRI, SIA, AIA)

Recruiting
  • Major Depressive Disorder
  • SSRI
  • +2 more
  • Hangzhou, Zhejiang, China
    the Third affiliated hospital of Zhejiang Chinese Medical univer
Apr 15, 2023

Haemorrhage Between Vortioxetine Tablet Treatment and Selective

Not yet recruiting
  • Major Depressive Disorder
  • Vortioxetine Tablet
  • SSRI
  • (no location specified)
Jun 28, 2023

Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • aiTBS
  • +2 more
  • Ghent, East-Flanders, Belgium
    University Hospital Ghent
Dec 6, 2022

SSRI's and the Rate of Progression From MCI to Dementia

Recruiting
  • Mild Cognitive Impairment
  • +2 more
  • SSRI
  • Columbus, Ohio
    The Ohio State University
Sep 8, 2021

MDD Trial in Hangzhou (SSRI, SIA, AIA)

Recruiting
  • Major Depressive Disorder
  • SSRI
  • +2 more
  • Hangzhou, Zhejiang, China
    the Third affiliated hospital of Zhejiang Chinese Medical univer
Jan 31, 2023

MDD Trial in Pittsburgh (SSRI, CBT)

Completed
  • Major Depressive Disorder
  • SSRI
  • CBT
  • Pittsburgh, Pennsylvania
    Mood Disorders Treatment and Research Program - UPMC
Jan 24, 2019

Internalizing Psychopathologies (IPs) Depression and Anxiety Trial in Chicago (SSRI, CBT)

Completed
  • Internalizing Psychopathologies (IPs) Depression and Anxiety
  • SSRI
  • CBT
  • Chicago, Illinois
    University of Illinois at Chicago
Oct 9, 2018

MDD Trial in Japan (LY2216684, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Chiba, Japan
  • +8 more
Mar 26, 2018

Depressive Disorder, Major Trial in Worldwide (LY2216684 (edivoxetine), SSRI)

Completed
Has Results
  • Depressive Disorder, Major
  • LY2216684 (edivoxetine)
  • SSRI
  • Birmingham, Alabama
  • +47 more
Mar 16, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +48 more
Mar 26, 2018

MDD (MDD) Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder (MDD)
  • Birmingham, Alabama
  • +53 more
Mar 25, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Irvine, California
  • +62 more
Mar 17, 2018

MDD Trial in Worldwide (Vortioxetine 10-20 mg, Placebo, SSRI)

Completed
  • Major Depressive Disorder
  • Vortioxetine 10-20 mg
  • +2 more
  • Tallinn, Estonia
  • +16 more
May 23, 2017

Patients With Chronic Stroke Trial in Chicago (SSRI, Placebo)

Completed
  • Patients With Chronic Stroke
  • SSRI
  • Placebo
  • Chicago, Illinois
    Rehabilitation Institute of Chicago
Dec 26, 2016

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Redlands, California
  • +76 more
Mar 16, 2018

OCD Trial in Canada, United States (Bitopertin, Placebo, SSRI)

Completed
  • Obsessive-Compulsive Disorder
  • Oceanside, California
  • +33 more
Jul 31, 2017

Depression, Epilepsy, Temporal Lobe Trial in MExico (Cognitive behavioral therapy, SSRI)

Completed
  • Depression
  • Epilepsy, Temporal Lobe
  • Cognitive behavioral therapy
  • SSRI
  • MExico, D.f., Mexico
    Instituto Nacional de Neurología y Neurocirugía MVS
Mar 27, 2015

MDD Trial in China (Effexor, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Beijing, Beijing, China
  • +25 more
Mar 2, 2012

Panic Disorder Trial in Melbourne (SSRI, CBT, CBT/SSRI)

Unknown status
  • Panic Disorder
  • SSRI
  • +2 more
  • Melbourne, Victoria, Australia
    Baker Heart Research Institute
Apr 4, 2007